by asormani
Posted on: January 9, 2013 by asormaniNo Comments »
Neurodevice firm SPR Therapeutics has raised $5 million in Series A financing from NDI Healthcare Fund, Public Square Partners, and individual investors. The funds will be used to commercialize pain therapies using SPR’s proprietary peripheral nerve stimulation technology.
Posted on: February 9, 2012 by Connie LoizosNo Comments »
Checkpoint Surgical, a Cleveland, Oh.-based neurostimulation company, has raised a $1.7 million Series B round of funding led by its main investor, NDI Healthcare Fund. NDI also runs the neurotechnology incubator that helped start Checkpoint. Three-year-old Checkpoint, whose flagship product is a muscle stimulator that helps surgeons locate and evaluate nerves during surgery, has also secured a [...]
The surging popularity of bitcoin has some brand-name venture capitalists investing real money in the controversial virtual currency. Just since
Author : laragon
TPG has had much luck tapping the IPO market during the past 12 months. The PE firm’s most recent success
Author : lbeltran
This week marks the one-year anniversary of Facebook’s public offering, one of the most highly anticipated market events in Wall
Author : connieloizos
Blackstone Group LP is planning to create a hedge fund which will consist of the boldest trades from the third-party
Author : reuters-news
Long before taking the helm as CEO of Twitter, Dick Costolo was an aspiring comic at Chicago’s famed The Second
Author : joanna
Welcome! Join the peHUB community to make connections, share your opinion, and follow your favorite authors. It's quick and easy.
Click here to get started!
asormani wrote a new post, Cotton Creek Adds to Investment Team 8 minutes ago
Cotton Creek Capital has added Clayton Milburn to the investment team as an associate in the Austin office. Previously, Milburn was an associate in the leveraged finance group at ORIX Corporate Capital, a […]
asormani wrote a new post, eFFECTOR Therapeutics Raises $45 Million Series A 10 minutes ago
Biopharmaceutical company eFFECTOR Therapeutics has completed a $45 million Series A financing. Investors include U.S. Venture Partners, Abingworth, Novartis Venture Funds, SR One, Astellas Venture Management, […]
asormani wrote a new post, NFP Names Doug Hammond CEO 19 minutes ago
National Financial Partners, a provider of benefits, insurance and wealth management services, has named Douglas W. Hammond, president and chief operating officer, as chief executive officer. Hammond succeeds […]
asormani wrote a new post, Oppenheimer’s Investment Banking Division Continues Growth 22 minutes ago
Oppenheimer & Co. Inc, a unit of Oppenheimer Holdings has made several senior hires. The recruitment drive includes two recent additions in the investment banking division: David Brown and Robert Cramer.
PRESS […]
asormani wrote a new post, VTL Associates Closes Growth Capital Investment 24 minutes ago
VTL Associates has secured an investment from Suzhou Industrial Park Kaida Venture Capital, an international venture capital firm based in Dalian, China. The growth capital will be used to support the expansion of […]
